目錄:MedChemExpress LLC>>生化試劑>> Etrumadenant | MCE
CAS | 2239273-34-6 | 純度 | 99.79% |
---|---|---|---|
分子量 | 426.47 | 分子式 | C??H??N?O |
供貨周期 | 現貨 | 規格 | 5 mg |
貨號 | HY-129393 | 應用領域 | 醫療衛生,化工,生物產業,制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務。
CAS No. : 2239273-34-6
產品活性:Etrumadenant (AB928) is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. Etrumadenant relieves adenosine-mediated immune suppression. Etrumadenant has immunomodulatory and antitumor activities.
研究領域:GPCR/G Protein
作用靶點:Adenosine Receptor
In Vitro: In human in vitro cell cultures, moDC differentiated in the presence of adenosine showed a decreased ability to stimulate IFN-γ secretion from allogenic CD4+ T-cells in a MLR. This suppression is significantly reversed by addition of Etrumadenant. Multiplexed gene expression profiling using NanoString identified a cassette of 39 genes that are regulated by adenosine during moDC differentiation. Etrumadenant shows rescue of these gene expression changes.
In Vivo: Concurrent treatment with Etrumadenant and chemotherapy results in significantly reduced tumor volume in vivo using AT3-OVA tumors; Similar results are observed for the combination of Etrumadenant and NSC 266046. AB928 is also capable of suppressing growth of B16-F10 tumors both as a single agent or in combination with α-PD-1 therapy. Etrumadenant increases the antitumor immune response leading to suppressed tumor growth and increased immune cell infiltration in mouse syngeneic tumors.
相關產品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Small Molecule Immuno-Oncology Compound Library | Drug Repurposing Compound Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | 2-Chloro-N-cyclopentyl-2′-C-methyladenosine | MRS-1191 | APNEA | HEMADO | A2A receptor antagonist 2 | Xanthine amine congener hydrochloride | Nitrobenzylthioinosine | Proxyphylline | N6-Cyclopentyladenosine | (Rac)-Mirabegron-d5 | Adenosine-2'-monophosphate | Norisoboldine | N-0861 racemate | MRS1177 | Regadenoson-d3 | MRS-1706 | Imaradenant | A1AR antagonist 2 | Adenosine 5'-monophosphate monohydrate | 5'-N-Ethylcarboxamidoadenosine | ST 1535 | Ticlopidine hydrochloride | Sulmazole | Adenosine antagonist-1 | Adenosine receptor antagonist 3 | Istradefylline | Sipagladenant | CV1808 | VCP171 | Acefylline
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產品,廣泛應用于新藥研發、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業技術服務;
• 設有專業的實驗中心和嚴格的質控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告,確保產品的高純度、高品質;
• 產品的生物活性多經各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業團隊跟蹤最新的制藥及生命科學研究進展,為您提供*新的活性化合物;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。